Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease
Open Access
- 18 October 2016
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2016, 1-12
Abstract
Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are both characterized by chronic low-grade inflammation. The role of Th17 and its related cytokines in T2DM and CAD is unclear. Here we investigated the serum levels of five Th17-related cytokines (IL-17, IL-22, MIP-3α, IL-9, and IL-27) in T2DM, CAD, and T2DM-CAD comorbidity patients. IL-22 was found to be elevated in all three conditions. Elevated serum IL-22 was independently associated with the incidence of T2DM and CAD. Conversely, IL-22 was found to protect endothelial cells from glucose- and lysophosphatidylcholine- (LPC-) induced injury, and IL-22R1 expression on endothelial cells was increased upon treatment with high glucose and LPC. Blocking of IL-22R1 with IL-22R1 antibody diminished the protective role of IL-22. Our results suggest that IL-22 functions as a double-edged sword in T2DM and CAD and that IL-22 may be used in the treatment of chronic inflammatory diseases such as T2DM and CAD.Keywords
Funding Information
- National Natural Science Foundation of China (81270428, 81300999, 81470501)
- National Natural Science Foundation of China (81270428, 81300999, 81470501)
- National Natural Science Foundation of China (81270428, 81300999, 81470501)
This publication has 34 references indexed in Scilit:
- IL-27 Induces Th17 Differentiation in the Absence of STAT1 SignalingThe Journal of Immunology, 2015
- Interleukin-22 Promotes Wound Repair in Diabetes by Improving Keratinocyte Pro-Healing FunctionsJournal of Investigative Dermatology, 2015
- Interleukin-22: Immunobiology and PathologyAnnual Review of Immunology, 2015
- Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stressNature Medicine, 2014
- Elevated Peripheral Frequencies of Th22 Cells: A Novel Potent Participant in Obesity and Type 2 DiabetesPLOS ONE, 2014
- Transforming Growth Factor–β Signaling in T Cells Promotes Stabilization of Atherosclerotic Plaques Through an Interleukin-17–Dependent PathwayScience Translational Medicine, 2013
- Interleukin-22 Ameliorates Cerulein-Induced Pancreatitis in Mice by Inhibiting the Autophagic PathwayInternational Journal of Biological Sciences, 2012
- INFLAMMATION AND ATHEROSCLEROSISAnnual Review of Pathology: Mechanisms of Disease, 2006
- IL-22 Increases the Innate Immunity of TissuesImmunity, 2004
- Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2003